Literature DB >> 77366

Clostridium difficile and the aetiology of pseudomembranous colitis.

H E Larson, A B Price, P Honour, S P Borriello.   

Abstract

Bacterial isolates from 5 patients with pseudomembranous colitis (P.M.C.) were screened for toxin production. Strains of Clostridium from 4 patients produced in vitro a toxin similar to that found in P.M.C. faecal suspension. These were identified as C. difficile. Use of the strains from 2 patients induced a fatal enterocolitis when inoculated orally into hamsters pretreated with vancomycin. The C. difficile that produced the toxin in vitro was then re-isolated from hamster caecal contents. These findings suggest that P.M.C. results from infection with C. difficile and that previous antibiotic therapy produces susceptibility to infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77366     DOI: 10.1016/s0140-6736(78)90912-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  172 in total

1.  Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization.

Authors:  A Tasteyre; M C Barc; A Collignon; H Boureau; T Karjalainen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

4.  Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916.

Authors:  H Hächler; F H Kayser; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus.

Authors:  H Hächler; B Berger-Bächi; F H Kayser
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

6.  Restriction endonuclease DNA analysis of Clostridium difficile.

Authors:  B W Wren; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

7.  Etiology of tetracycline-associated pseudomembranous colitis in hamsters.

Authors:  R Toshniwal; R Fekety; J Silva
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Ultrastructural changes of cultured human amnion cells by Clostridiu difficile toxin.

Authors:  T W Chang; P S Lin; S L Gorbach; J G Bartlett
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Antitoxin production in antibiotic-associated colitis?

Authors:  A H Lishman; I J Al-Jumaili; C O Record
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.